Valuation: BGI Genomics Co., Ltd.

Capitalization 17.73B 2.44B 2.33B 2.17B 1.92B 3.46B 207B 3.82B 26.8B 9.94B 85.13B 9.17B 8.96B 371B P/E ratio 2022
26.4x
P/E ratio 2023 213x
Enterprise value 12.61B 1.74B 1.65B 1.54B 1.37B 2.46B 147B 2.72B 19.06B 7.07B 60.54B 6.52B 6.37B 264B EV / Sales 2022
2.13x
EV / Sales 2023 3.35x
Free-Float
52.36%
Yield 2022
1.93%
Yield 2023 0.21%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.86%
1 week+2.20%
Current month+1.93%
1 month-7.72%
3 months+33.70%
6 months+21.00%
Current year-3.12%
More quotes
1 week
46.30
Extreme 46.3
49.50
1 month
43.75
Extreme 43.75
49.56
Current year
33.00
Extreme 33
56.89
1 year
33.00
Extreme 33
56.89
3 years
33.00
Extreme 33
105.66
5 years
33.00
Extreme 33
199.40
10 years
16.37
Extreme 16.37
261.99
More quotes
Director TitleAgeSince
Chief Executive Officer - 2021-06-15
Director of Finance/CFO 46 2021-06-15
Chief Operating Officer 47 2023-06-28
Manager TitleAgeSince
Chairman 70 1999-09-08
Director/Board Member 45 2021-06-15
Director/Board Member 40 2015-06-21
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.86%+2.20%-5.26%-49.57%2.49B
-1.78%-1.55%-9.19%-21.19%11.57B
-2.56%-1.99%+57.39%+7.00%3.44B
-2.26%-14.06%+5.58%-57.39%2.43B
-3.09%-8.99%+116.02%-45.83%1.26B
-0.08%-2.63%+23.08%-77.52%909M
-0.27%+10.79%-5.65%-86.08%803M
+0.22%+2.87%+1.97%-63.88%752M
+2.84%+4.39%+126.34%+131.04%243M
+4.48%+1.73%-3.61% - 216M
Average -0.42%+3.05%+30.67%-29.27% 2.41B
Weighted average by Cap. -1.70%+0.20%+11.86%-29.17%
See all sector performances

Financials

2022 2023
Net sales 7.05B 970M 924M 861M 763M 1.38B 82.29B 1.52B 10.65B 3.95B 33.82B 3.64B 3.56B 148B 4.35B 599M 571M 532M 471M 849M 50.8B 938M 6.57B 2.44B 20.88B 2.25B 2.2B 91.11B
Net income 803M 110M 105M 98.15M 86.99M 157M 9.38B 173M 1.21B 450M 3.85B 415M 406M 16.82B 92.9M 12.78M 12.19M 11.36M 10.06M 18.13M 1.08B 20.03M 140M 52.06M 446M 48.04M 46.96M 1.95B
Net Debt -6.21B -854M -815M -759M -673M -1.21B -72.51B -1.34B -9.39B -3.48B -29.81B -3.21B -3.14B -130B -5.12B -705M -672M -626M -555M -1B -59.8B -1.1B -7.74B -2.87B -24.58B -2.65B -2.59B -107B
More financial data * Estimated data
Logo BGI Genomics Co., Ltd.
BGI Genomics Co., Ltd. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.
Employees
-
More about the company
Date Price Change Volume
24-12-12 46.50 ¥ -1.86% 3,984,432
24-12-12 47.38 ¥ -0.48% 3,153,800
24-12-11 47.61 ¥ +0.21% 3,168,316
24-12-10 47.51 ¥ -0.57% 5,587,894
24-12-09 47.78 ¥ +0.44% 6,432,770

End-of-day quote Shenzhen S.E., December 12, 2024

More quotes

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300676 Stock